Table 1.
Patient characteristics.
| Characteristics | All Patients n = 51 | Patients Referred for Primary Staging n = 39 |
|---|---|---|
| Age (mean and 95% CI) | 67.2 (64.8–69.6) | 65.6 (62.9–68.3) |
| Reason for referral | ||
| Primary staging | 39 (76%) | 39 (100%) |
| Increasing PSA | 8 (16%) | n/a |
| Other reasons | 4 (8%) | n/a |
| PSA | ||
| < 10 ng/ml | 11 (22%) | 10 (26%) |
| 10–20 ng/ml | 19 (37%) | 16 (41%) |
| > 20 ng/ml | 17 (33%) | 13 (33%) |
| n/a a | 4 (8%) | 0 (0%) |
| Tumor stage | ||
| ≤ T2a | 22 (43%) | 14 (36%) |
| T2b | 6 (12%) | 6 (15%) |
| ≥ T2c | 19 (37%) | 19 (49%) |
| n/a a | 4 (8%) | 0 (0%) |
| Gleason | ||
| ≤ 6 | 4 (8%) | 2 (5%) |
| 7 (3+4) | 14 (27%) | 10 (26%) |
| 7 (4+3) | 11 (22%) | 10 (26%) |
| ≥ 8 | 18 (35%) | 17 (44%) |
| n/a a | 4 (8%) | 0 (0%) |
| D’Amico risk classification | ||
| Low risk | 1 (2%) | 0 (0%) |
| Intermediate risk | 14 (27%) | 12 (31%) |
| High risk | 32 (63%) | 27 (69%) |
| n/a a | 4 (8%) | 0 (0%) |
a n/a: Not applicable. Three patients had biochemical recurrence after radical prostatectomy, and one had lymph node metastases.